1. Home
  2. ASRT vs SCWO Comparison

ASRT vs SCWO Comparison

Compare ASRT & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • SCWO
  • Stock Information
  • Founded
  • ASRT 1995
  • SCWO 2021
  • Country
  • ASRT United States
  • SCWO United States
  • Employees
  • ASRT N/A
  • SCWO N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • ASRT Health Care
  • SCWO Utilities
  • Exchange
  • ASRT Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • ASRT 78.3M
  • SCWO 64.3M
  • IPO Year
  • ASRT 1997
  • SCWO N/A
  • Fundamental
  • Price
  • ASRT $0.86
  • SCWO $0.38
  • Analyst Decision
  • ASRT Strong Buy
  • SCWO
  • Analyst Count
  • ASRT 4
  • SCWO 0
  • Target Price
  • ASRT $3.19
  • SCWO N/A
  • AVG Volume (30 Days)
  • ASRT 362.0K
  • SCWO 300.3K
  • Earning Date
  • ASRT 03-10-2025
  • SCWO 03-28-2025
  • Dividend Yield
  • ASRT N/A
  • SCWO N/A
  • EPS Growth
  • ASRT N/A
  • SCWO N/A
  • EPS
  • ASRT N/A
  • SCWO N/A
  • Revenue
  • ASRT $125,763,000.00
  • SCWO $313,930.00
  • Revenue This Year
  • ASRT N/A
  • SCWO N/A
  • Revenue Next Year
  • ASRT $1.84
  • SCWO $5,180.00
  • P/E Ratio
  • ASRT N/A
  • SCWO N/A
  • Revenue Growth
  • ASRT N/A
  • SCWO N/A
  • 52 Week Low
  • ASRT $0.73
  • SCWO $0.36
  • 52 Week High
  • ASRT $1.80
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 39.72
  • SCWO 23.40
  • Support Level
  • ASRT $0.78
  • SCWO $0.54
  • Resistance Level
  • ASRT $0.83
  • SCWO $0.58
  • Average True Range (ATR)
  • ASRT 0.03
  • SCWO 0.06
  • MACD
  • ASRT 0.00
  • SCWO -0.00
  • Stochastic Oscillator
  • ASRT 4.57
  • SCWO 17.29

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: